The Effect of Su Jok Application on Pain, Anxiety and Comfort Levels After Cesarean Section

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorAtaturk University

About this trial

Objective: To determine the effect of Su Jok application on pain, anxiety and comfort level after cesarean section. The research will be conducted as a randomized controlled experimental study with pretest-posttest control group

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being between 18-35 years of age

Having at least primary school education

Not having any health problems (such as hypertension, tuberculosis, cancer)

Not having hearing and vision problem

Disqualifiers

Postpartum hemorrhage

Incomplete completion of the application stages

Complications during the application process

Voluntary withdrawal of the woman from the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Su Jok Application

    Other intervention

    The patient's hands will be preferred for the application due to the comfort and convenience of the woman after cesarean section. Su Jok therapy, massage and seed will be applied to the reflection points on the hand based on the area to be treated.

  • Placebo Application

    Other intervention

    Placebo Intervention: The placebo group will be massaged and seed will be applied to an area where there is no reflection of the Su Jok organ.

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Experimental GroupExperimental treatment 1 intervention
Group B: Placebo GroupPlacebo comparator 1 intervention
Group C: No Intervention : Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Personal Information Form

There are 21 questions in this form, prepared by the researchers in line with the literature

Time frame
10 months
2

Visual Analog Scale (VAS)

The Visual Analog Scale is an assessment tool in which patients mark on a 10 cm ruler. The 10 cm scale, which is a numerical pain assessment scale, starts with "No pain (0)" and ends with "Intolerable pain (10)". The patient is asked to mark the place on the line that expresses pain. The distance marked by the patient is measured by taking zero as the starting distance. In this way, the patient's pain level is determined. In this study, a horizontal VAS will be used to assess pain intensity. The reason for choosing this scale in the study is that it is easy to understand and easy to use by the participants.

Time frame
10 months
3

Verbal Category Scale

The scale is based on the selection of the most appropriate word to describe the patient's pain condition. The pain of the patients is evaluated with the scoring method 'No Pain 0 points, Very Mild Pain 2 points, Mild Pain 4 points, Severe Pain 6 points, Very Severe Pain 8 points, Unbearable Pain 10 points'. The patient will be asked to select the appropriate pain level. The scale is easy to apply and easy to classify.

Time frame
10 months
4

Spielberg State Anxiety Scale

This scale was developed by Spielberger et al. Developed by. The adaptation of the scale to Turkish and its validity and reliability studies were carried out by Öner and Le Compte in 1983.The scale is a 4-point Likert scale consisting of the options "not at all", "somewhat", "a lot", "completely". There are 10 direct and 10 reversed statements in the scale. Positive (increasing the total anxiety score) for items 3, 4, 6, 7, 9, 12, 13, 14, 17, 18 in the scale; 1, 2, 5, 8, 10, 11, 15, 16, 19 Negative scores (reducing the total anxiety score) are obtained for the 20th items. The highest score is 80 and the lowest score is 20. A high total score indicates that the person's anxiety level is also high.Cronbach's alpha coefficient was found to be 0.79 for state anxiety. In this study, Cronbach's Alpha value was found to be 0.83.

Time frame
10 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: